Tavexia Lifecare Board to Deliberate Meyonex Pharmaceuticals Acquisition on 7th Oct'26
Sattva Sukun Lifecare Ltd 路 Intimation 路 07 Oct 2026, 5:30 am
Tavexia Lifecare Board to Deliberate Meyonex Pharmaceuticals Acquisition on 7th Oct'26 Tavexia Lifecare Limited has scheduled a Board of Directors meeting on 7th Oct'26 to discuss and determine the next course of action regarding its proposed acquisition of up to a 60% equity stake in unlisted entity Meyonex Pharmaceuticals Limited. This follows the prior board approval on 7th Sep'26 authorizing preliminary due diligence, valuation, and negotiations. Additionally, the trading window for designated persons remains closed from 30th Sep'26 until 48 hours post the declaration of H1'27 financial results.
Original exchange filing (PDF)
More announcements from Sattva Sukun Lifecare Ltd
- Financial Result 路 05 Nov 2026
- Announcement 路 05 Nov 2026
- Board has Approved in Change in RTA 路 05 Nov 2026
- Result 路 05 Nov 2026
- Outcome of Board Meeting 路 05 Nov 2026
- Tavexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting 路 04 Nov 2026
- Announcement 路 13 Oct 2026
- Disclosure under regulation 30 路 12 Oct 2026
